In conclusion, the study by Chalermpalanupap and colleagues provides longitudinal evidence that a combination of LC neurodegeneration and tau pathology synergistically impairs learning and memory and exacerbates neuropathology in a transgenic mouse model of tauopathy. The gene discussed is MAPT; the disease is tauopathy.